IL18 and metabolic syndrome: Compared with Il18+/+ mice, Il18−/− mice developed kidney failure in their youth-6 weeks of age, but the condition was observed to improve as the mice aged, even though dyslipidemia, arteriosclerosis, and higher insulin resistance occurred.